127 related articles for article (PubMed ID: 34357761)
1. Diastereoselective Synthesis of a
Majima K; Yamano M
J Org Chem; 2021 Sep; 86(17):11464-11471. PubMed ID: 34357761
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric Synthesis of a 5,6,7,8-Tetrahydro-1,6-naphthyridine Scaffold Leading to Potent Retinoid-Related Orphan Receptor γt Inverse Agonist TAK-828F.
Tsuruoka R; Yoshikawa N; Konishi T; Yamano M
J Org Chem; 2020 Aug; 85(16):10797-10805. PubMed ID: 32701287
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Evaluation of TAK-828F, a Novel Orally Available RORγt Inverse Agonist, on Murine Colitis Model.
Igaki K; Nakamura Y; Komoike Y; Uga K; Shibata A; Ishimura Y; Yamasaki M; Tsukimi Y; Tsuchimori N
Inflammation; 2019 Feb; 42(1):91-102. PubMed ID: 30121880
[TBL] [Abstract][Full Text] [Related]
4. Discovery of [ cis-3-({(5 R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1 H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5 H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist.
Kono M; Ochida A; Oda T; Imada T; Banno Y; Taya N; Masada S; Kawamoto T; Yonemori K; Nara Y; Fukase Y; Yukawa T; Tokuhara H; Skene R; Sang BC; Hoffman ID; Snell GP; Uga K; Shibata A; Igaki K; Nakamura Y; Nakagawa H; Tsuchimori N; Yamasaki M; Shirai J; Yamamoto S
J Med Chem; 2018 Apr; 61(7):2973-2988. PubMed ID: 29510038
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist.
Shibata A; Uga K; Sato T; Sagara M; Igaki K; Nakamura Y; Ochida A; Kono M; Shirai J; Yamamoto S; Yamasaki M; Tsuchimori N
Biochem Pharmacol; 2018 Apr; 150():35-45. PubMed ID: 29369782
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological evaluation of TAK-828F, a novel orally available RORγt inverse agonist, on murine chronic experimental autoimmune encephalomyelitis model.
Nakamura Y; Igaki K; Uga K; Shibata A; Yamauchi H; Yamasaki M; Tsuchimori N
J Neuroimmunol; 2019 Oct; 335():577016. PubMed ID: 31374381
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel disease.
Igaki K; Nakamura Y; Tanaka M; Mizuno S; Yoshimatsu Y; Komoike Y; Uga K; Shibata A; Imaichi H; Takayuki S; Ishimura Y; Yamasaki M; Kanai T; Tsukimi Y; Tsuchimori N
Inflamm Res; 2019 Jun; 68(6):493-509. PubMed ID: 30972425
[TBL] [Abstract][Full Text] [Related]
8. Biochemical Properties of TAK-828F, a Potent and Selective Retinoid-Related Orphan Receptor Gamma t Inverse Agonist.
Nakagawa H; Koyama R; Kamada Y; Ochida A; Kono M; Shirai J; Yamamoto S; Ambrus-Aikelin G; Sang BC; Nakayama M
Pharmacology; 2018; 102(5-6):244-252. PubMed ID: 30134246
[TBL] [Abstract][Full Text] [Related]
9. 1,5-Disubstituted Acylated 2-Amino-4,5-dihydroimidazoles as a New Class of Retinoic Acid Receptor-Related Orphan Receptor (ROR) Inhibitors.
Ortiz MA; Piedrafita FJ; Nefzi A
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457251
[TBL] [Abstract][Full Text] [Related]
10. AhR-ROR-γt complex is a therapeutic target for MAP4K3/GLK
Chuang HC; Chen YM; Chen MH; Hung WT; Yang HY; Tseng YH; Tan TH
FASEB J; 2019 Oct; 33(10):11469-11480. PubMed ID: 31318609
[TBL] [Abstract][Full Text] [Related]
11. Discovery, Synthesis, and In Vitro Characterization of 2,3 Derivatives of 4,5,6,7-Tetrahydro-Benzothiophene as Potent Modulators of Retinoic Acid Receptor-Related Orphan Receptor γt.
Fouda A; Negi S; Zaremba O; Gaidar RS; Moroz YS; Rusanov E; Paraskevas S; Tchervenkov J
J Med Chem; 2023 Jun; 66(11):7355-7373. PubMed ID: 37172324
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel ROR inverse agonists with a dibenzosilole scaffold as a hydrophobic core structure.
Toyama H; Nakamura M; Hashimoto Y; Fujii S
Bioorg Med Chem; 2015 Jul; 23(13):2982-8. PubMed ID: 26014484
[TBL] [Abstract][Full Text] [Related]
13. Substituted diaryl ether compounds as retinoic acid-related orphan Receptor-γt (RORγt) agonists.
Ruan Z; Park PK; Wei D; Purandare A; Wan H; O'Malley D; Stachura S; Perez H; Cavallaro CL; Weigelt CA; Sack JS; Ruzanov M; Khan J; Gururajan M; Wong JJ; Huang Y; Yarde M; Li Z; Chen C; Sun H; Borowski V; Xie JH; Anthony M; Agler M; Fink BE; Harikrishnan LS
Bioorg Med Chem Lett; 2021 Mar; 35():127778. PubMed ID: 33422603
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Biological Evaluation of Retinoic Acid-Related Orphan Receptor γt (RORγt) Agonist Structure-Based Functionality Switching Approach from In House RORγt Inverse Agonist to RORγt Agonist.
Yukawa T; Nara Y; Kono M; Sato A; Oda T; Takagi T; Sato T; Banno Y; Taya N; Imada T; Shiokawa Z; Negoro N; Kawamoto T; Koyama R; Uchiyama N; Skene R; Hoffman I; Chen CH; Sang B; Snell G; Katsuyama R; Yamamoto S; Shirai J
J Med Chem; 2019 Feb; 62(3):1167-1179. PubMed ID: 30652849
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases.
Sun N; Ma X; Zhou K; Zhu C; Cao Z; Wang Y; Xu J; Fu W
Eur J Med Chem; 2020 Feb; 187():111984. PubMed ID: 31881455
[TBL] [Abstract][Full Text] [Related]
16. The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes.
Jetten AM; Kurebayashi S; Ueda E
Prog Nucleic Acid Res Mol Biol; 2001; 69():205-47. PubMed ID: 11550795
[TBL] [Abstract][Full Text] [Related]
17. Discovery and Optimization of a Series of Sulfonamide Inverse Agonists for the Retinoic Acid Receptor-Related Orphan Receptor-α.
Doebelin C; He Y; Campbell S; Nuhant P; Kumar N; Koenig M; Garcia-Ordonez R; Chang MR; Roush WR; Lin L; Kahn S; Cameron MD; Griffin PR; Solt LA; Kamenecka TM
Med Chem; 2019; 15(6):676-684. PubMed ID: 30799793
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel N-sulfonamide-tetrahydroisoquinolines as potent retinoic acid receptor-related orphan receptor γt agonists.
Ma X; Sun N; Li X; Fu W
Eur J Med Chem; 2021 Oct; 222():113585. PubMed ID: 34118722
[TBL] [Abstract][Full Text] [Related]
19. ROR gamma: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle.
Hirose T; Smith RJ; Jetten AM
Biochem Biophys Res Commun; 1994 Dec; 205(3):1976-83. PubMed ID: 7811290
[TBL] [Abstract][Full Text] [Related]
20. Agonist Lock Touched and Untouched Retinoic Acid Receptor-Related Orphan Receptor-γt (RORγt) Inverse Agonists: Classification Based on the Molecular Mechanisms of Action.
Sun N; Xie Q; Dang Y; Wang Y
J Med Chem; 2021 Aug; 64(15):10519-10536. PubMed ID: 34264059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
